The regulatory actions were based on results from the Phase III MATTERHORN trial (NCT04592913), which showed that a ...

Under terms of the deal, Bavarian Nordic shareholders will receive an all-cash offer at a premium, with plans to delist the ...

A special segment of “Empowered with Meg Ryan” featuring a collaboration with Kings View will air for public television users ...

Gen Li, president and founder of Phesi, spoke with Pharmaceutical Executive about issues pharma companies are having during ...

The latest announcement comes from Simtra BioPharma Solutions, a global CDMO, with US headquarters located in Parsippany, NJ.

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...

Dr. Zeskind discusses how Immuneering’s treatments can impact a broad range of cancer types. Dr. Ben Zeskind, CEO and ...